Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19880783rdf:typepubmed:Citationlld:pubmed
pubmed-article:19880783lifeskim:mentionsumls-concept:C0013018lld:lifeskim
pubmed-article:19880783lifeskim:mentionsumls-concept:C0150369lld:lifeskim
pubmed-article:19880783lifeskim:mentionsumls-concept:C0333678lld:lifeskim
pubmed-article:19880783lifeskim:mentionsumls-concept:C0005773lld:lifeskim
pubmed-article:19880783lifeskim:mentionsumls-concept:C1504389lld:lifeskim
pubmed-article:19880783lifeskim:mentionsumls-concept:C0035020lld:lifeskim
pubmed-article:19880783lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:19880783lifeskim:mentionsumls-concept:C1332710lld:lifeskim
pubmed-article:19880783lifeskim:mentionsumls-concept:C1947906lld:lifeskim
pubmed-article:19880783lifeskim:mentionsumls-concept:C1515895lld:lifeskim
pubmed-article:19880783lifeskim:mentionsumls-concept:C0332324lld:lifeskim
pubmed-article:19880783pubmed:issue11lld:pubmed
pubmed-article:19880783pubmed:dateCreated2009-11-2lld:pubmed
pubmed-article:19880783pubmed:abstractTextAnalysis of donor chimerism is an important diagnostic tool to assess the risk of relapse after allogeneic stem cell transplantation, especially in patients lacking a specific marker suitable for monitoring of minimal residual disease. We prospectively investigated the predictive value of donor chimerism analyses in sorted CD34(+) peripheral blood cells in 90 patients with acute leukemia and myelodysplastic syndrome. The cumulative incidence of relapse after four years was significantly increased in cases with decreasing or incomplete CD34(+) donor chimerism (57% vs. 18%, p=0.0001). Multivariate analysis confirmed decreasing CD34(+) donor chimerism as an independent predictor of relapse and inferior survival. The interval between a decrease of CD34(+) chimerism of less than 80% and hematologic relapse was 61 days (range 0-567). Monitoring of CD34(+) donor chimerism in the peripheral blood allows prediction of imminent relapse after allogeneic stem cell transplantation even when a disease-specific marker is lacking.lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:languageenglld:pubmed
pubmed-article:19880783pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:citationSubsetIMlld:pubmed
pubmed-article:19880783pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19880783pubmed:statusMEDLINElld:pubmed
pubmed-article:19880783pubmed:monthNovlld:pubmed
pubmed-article:19880783pubmed:issn1592-8721lld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:FauserAxel...lld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:KleinStefanSlld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:ScheteligJoha...lld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:ThiedeChristi...lld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:BornhäuserMar...lld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:EhningerGerha...lld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:MartinHansHlld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:MohrBrigitteBlld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:BrendelCornel...lld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:PlatzbeckerUw...lld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:SchaichMarkus...lld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:IllmerThomasTlld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:TheuserCatrin...lld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:KiehlMichael...lld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:KianiAlexande...lld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:BugGesineGlld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:OelschlaegelU...lld:pubmed
pubmed-article:19880783pubmed:authorpubmed-author:LutterbeckKar...lld:pubmed
pubmed-article:19880783pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19880783pubmed:volume94lld:pubmed
pubmed-article:19880783pubmed:ownerNLMlld:pubmed
pubmed-article:19880783pubmed:authorsCompleteYlld:pubmed
pubmed-article:19880783pubmed:pagination1613-7lld:pubmed
pubmed-article:19880783pubmed:dateRevised2010-9-28lld:pubmed
pubmed-article:19880783pubmed:meshHeadingpubmed-meshheading:19880783...lld:pubmed
pubmed-article:19880783pubmed:meshHeadingpubmed-meshheading:19880783...lld:pubmed
pubmed-article:19880783pubmed:meshHeadingpubmed-meshheading:19880783...lld:pubmed
pubmed-article:19880783pubmed:meshHeadingpubmed-meshheading:19880783...lld:pubmed
pubmed-article:19880783pubmed:meshHeadingpubmed-meshheading:19880783...lld:pubmed
pubmed-article:19880783pubmed:meshHeadingpubmed-meshheading:19880783...lld:pubmed
pubmed-article:19880783pubmed:meshHeadingpubmed-meshheading:19880783...lld:pubmed
pubmed-article:19880783pubmed:meshHeadingpubmed-meshheading:19880783...lld:pubmed
pubmed-article:19880783pubmed:meshHeadingpubmed-meshheading:19880783...lld:pubmed
pubmed-article:19880783pubmed:meshHeadingpubmed-meshheading:19880783...lld:pubmed
pubmed-article:19880783pubmed:meshHeadingpubmed-meshheading:19880783...lld:pubmed
pubmed-article:19880783pubmed:year2009lld:pubmed
pubmed-article:19880783pubmed:articleTitleMonitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation.lld:pubmed
pubmed-article:19880783pubmed:affiliationMedizinische Klinik und Poliklinik I, University Hospital, Dresden, Germany. martin.bornhaeuser@uniklinikum-dresden.delld:pubmed
pubmed-article:19880783pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19880783pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19880783lld:pubmed